1-3 of 3
Charles C. Williams
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors

Free
Jhanelle E. Gray, Eric Haura, Alberto Chiappori, Tawee Tanvetyanon, Charles C. Williams, Mary Pinder-Schenck, Julie A. Kish, Jenny Kreahling, Richard Lush, Anthony Neuger, Leticia Tetteh, Angela Akar, Xiuhua Zhao, Michael J. Schell, Gerold Bepler, Soner Altiok
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1644–1655.
https://doi.org/10.1158/1078-0432.CCR-13-2235
Published: 13 March 2014
View articletitled, A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors
Open the PDF for A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors in another window
Journal Articles

Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study

Free
George R. Simon, Christopher R. Garrett, Stephen C. Olson, Michael Langevin, Irene A. Eiseman, John J. Mahany, Charles C. Williams, Richard Lush, Adil Daud, Pamela Munster, Alberto Chiappori, Mayer Fishman, Gerold Bepler, Peter F. Lenehan, Daniel M. Sullivan
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4645–4651.
https://doi.org/10.1158/1078-0432.CCR-05-2379
Published: 09 August 2006
View articletitled, Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study
Open the PDF for Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study in another window
Journal Articles

Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies

Free
Christopher R. Garrett, Mayer N. Fishman, Randall R. Rago, Charles C. Williams, Anne M. Dellaportas, J. Joseph Mahany, Richard M. Lush, William S. Dalton, Ashwin Gollerkeri, Marvin B. Cohen, Daniel M. Sullivan
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3335–3341.
https://doi.org/10.1158/1078-0432.CCR-04-1494
Published: 02 May 2005
View articletitled, Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies
Open the PDF for Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies in another window